Evaluation of choline acetyltransferase gene polymorphism (2384 G/A) in Alzheimer's disease and mild cognitive impairment

Dementia and Geriatric Cognitive Disorders

Volumn 26, Issue 1, 2008, Pages 9-14

  Tang, Muni ^a,b   Rao, Dongping ^a   Ma, Cui ^a   Guo, Yangbo ^a   Han, Haiying ^a   Ling, Kangguang ^a   Ling, Yuhua ^a  

^a GUANGZHOU MEDICAL UNIVERSITY   (China)

^b Guangzhou Brain Hospital   (China)

Author keywords

Alzheimer's disease; Chinese population; Choline acetyltransferase; Gene polymorphism; Mild cognitive impairment

Indexed keywords

CHOLINE ACETYLTRANSFERASE;

AGED; ALZHEIMER DISEASE; APTITUDE TEST; ARTICLE; CASE CONTROL STUDY; CHINESE; CHOLINE ACETYLTRANSFERASE GENE; CONTROLLED STUDY; DEMENTIA; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DISEASE ASSOCIATION; DNA POLYMORPHISM; EVALUATION; FEMALE; GENE; GENE FREQUENCY; GENOTYPE; HETEROZYGOTE; HUMAN; MAJOR CLINICAL STUDY; MALE; ONSET AGE; PRIORITY JOURNAL; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM;

AGE OF ONSET; AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; ASIAN CONTINENTAL ANCESTRY GROUP; CHOLINE O-ACETYLTRANSFERASE; COGNITION DISORDERS; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MALE; NEUROPSYCHOLOGICAL TESTS; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS; SEVERITY OF ILLNESS INDEX;

EID: 47949092382     PISSN: 14208008     EISSN: None     Source Type: Journal    
DOI: 10.1159/000140612     Document Type: Article

References (33)

1. Bales KR, Dodart JC, DeMattos RB, Holtzman DM, Paul SM: Apolipoprotein E, amyloid, and Alzheimer disease. Mol Interv 2002;2:363-375.
2. Myers AJ, Goate AM: The genetics of late-onset Alzheimer's disease. Curr Opin Neurol 2001;14:433-440.
3. Muir JL: Acetylcholine, aging and Alzheimer's disease. Pharmacol Biochem Behav 1997;56:687-696.
4. DeKosky ST, Ikonomovic MD, Styren SD, Beckett L, Wisniewski S, Bennett DA, Cochran EJ, Kordower JH, Mufson EJ: Upregulation of choline acetyltransferase activity in hippocampus and frontal cortex of elderly subjects with mild cognitive impairment. Ann Neurol 2002;51:145-155.
5. Baskin DS, Browning JL, Pirozzolo FJ, Korporaal S, Baskin JA, Appel SH: Brain choline acetyltransferase and mental function in Alzheimer disease. Arch Neurol 1999;56:1121-1123.
6. Erickson JD, Varoqui H, Schafer MK, Modi W, Diebler MF, Weihe E, Rand J, Eiden LE, Bonner TI, Usdin TB: Functional identification of a vesicular acetylcholine transporter and its expression from a 'cholinergic' gene locus. J Biol Chem 1994;269:21929-21932.
7. Mubumbila V, Sutter A, Ptok U, Heun R, Quirin-Stricker C: Identification of a single nucleotide polymorphism in the choline acetyltransferase gene associated with Alzheimer's disease. Neurosci Lett 2002;333:9-12.
8. Kozak M: Recognition of AUG and alternative initiator codons is augmented by G in position +4 but is not generally affected by the nucleotides in positions +5 and +6. EMBO J 1997;16:2482-2492.
9. Ahn Jo S, Ahn K, Kim JH, Kang BH, Kim E, Jo I, Kim DK: ApoE-epsilon 4-dependent association of the choline acetyltransferase gene polymorphisms (2384G → A and 1882G → A) with Alzheimer's disease. Clin Chim Acta 2006; 368: 179-182.
10. Kim KW, Suh YJ, Park WY, Jhoo JH, Lee DY, Youn JC, Lee KH, Seo JS, Woo JI: Choline acetyltransferase G +4 A polymorphism confers a risk for Alzheimer's disease in concert with Apolipoprotein E epsilon4. Neurosci Lett 2004;366:182-186.
11. Schwarz S, Eisele T, Diehl J, Müller U, Förstl H, Kurz A, Riemenschneider M: Lack of association between a single nucleotide polymorphism within the choline acetyltransferase gene and patients with Alzheimer's disease. Neurosci Lett 2003;343:167-170.
12. Cook LJ, Ho LW, Wang L, Terrenoire E, Brayne C, Evans JG, Xuereb J, Cairns NJ, Turic D, Hollingworth P, Moore PJ, Jehu L, Archer N, Walter S, Foy C, Edmondson A, Powell J, Lovestone S, Williams J, Rubinsztein DC: Candidate gene association studies of genes involved in neuronal cholinergic transmission in Alzheimer's disease suggests choline acetyltransferase as a candidate deserving further study. Am J Med Genet B Neuropsychiatr Genet 2005;132:5-8.
13. Ozturk A, DeKosky ST, Kamboh MI: Genetic variation in the choline acetyltransferase (CHAT) gene may be associated with the risk of Alzheimer's disease. Neurobiol Aging 2006;27:1440-1444.
14. American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, ed 4. Washington, American Psychiatric Association, 1994.
15. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM: Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Service Task Force on Alzheimer's Disease. Neurology 1984;34:939-944.
16. Petersen RC, Smith GE, Waring SC, Ivnik RJ, Tanqalos EG, Kokmen E: Mild cognitive impairment: clinical characterization and outcome. Arch Neurol 1999;56:303-308.
17. Hughes CP, Berg L, Danziger WL, Coben LA, Martin RL: A new clinical scale for the staging of dementia. Br J Psychiatry 1982;140:566-572.
18. Tang MN, Liu XH, Zou XY: The prevalence of senile dementia in the urban and the rural areas in Chengdu. Chin J Psychiatry 2001;34:226-230.
19. Chen P, Yu ES, Zhang M, Liu WT, Hill R, Katzman R: ADL dependence and medical conditions in Chinese older persons: a population-based survey in Shanghai, China. J Am Geriatr Soc 1995;43:378-383.
20. Fuld PA: The Fuld Object Memory Test. Chicago, Stoelting, 1981.
21. Butters N, Granholm E, Salmon DP, Wolfe J: Episodic and semantic memory: a comparison of amnesic and demented patients. J Clin Exp Neuropsychol 1987;9:479-497.
22. Gong YX: Handbook of Wechsler Adult Intelligence Scale-revised. Chinese version. Hunan, China, 1982.
23. Panza F, Solfrizzi V, Torres F, Mastroianni F, Del Pariqi A, Colacicco AM, Basile AM, Capurso C: Decreased frequency of apolipoprotein E epsilon4 allele from Northern to Southern Europe in Alzheimer's disease patients and centenarians. Neurosci Lett 1999;277:53-56.
24. Bertram L, McQueen MB, Mullin K, Blacker D, Tanzi RE: Systematic meta-analyses of Alzheimer disease genetic association studies: the AlzGene database. Nat Genet 2007;39:17-23.
25. Harold D, Peirce T, Moskvina V, Myers A, Jones S, Hollingworth P, Moore P, Lovestone S, Powell J, Foy C, Archer N, Walter S, Edmonson A, McIlroy S, Craig D, Passmore PA, Goate A, Hardy J, O'Donovan M, Williams J, Liddell M, Owen MJ, Jones L: Sequence variation in the CHAT locus shows no association with late-onset Alzheimer's disease. Hum Genet 2003;113:258-267.
26. Perry E, Walker M, Grace J, Perry R: Acetylcholine in mind: a neurotransmitter correlate of consciousness? Trends Neurosci 1999;22:273-280.
27. Deutsch JA: The cholinergic synapse and the size of memory. Science 1971;174:788-794.
28. Bartus RT: On neurodegenerative diseases, models, and treatment strategies: lessons learned and lessons forgotten a generation following the cholinergic hypothesis. Exp Neurol 2000;163:495-529.
29. Sarter M, Bruno JP: Developmental origins of the age-related decline in cortical cholinergic function and associated cognitive abilities. Neurobiol Aging 2004;25:1127-1139.
30. Bohnen NI, Kaufer DI, Hendrickson R, Ivanco LS, Lopresti B, Davis JG, Constantine G, Mathis CA, Moore RY, Dekoskv ST: Cognitive correlates of alterations in acetylcholinesterase in Alzheimer's disease. Neurosci Lett 2005;380:127-132.
31. Behl P, Bocti C, Swartz RH, Gao E, Sahlas DJ, Lanctot KL, Streiner DL, Black SE: Strategic subcortical hyperintensities in cholinergic pathways and executive function decline in treated Alzheimer patients. Arch Neurol 2007;64:266-272.
32. Nordberg A, Svensson AL: Cholinesterase inhibitors in the treatment of Alzheimer's disease: a comparison of tolerability and pharmacology. Drug Saf 1998;19:465-480.
33. Ikonomovic MD, Mufson EJ, Wuu J, Cochran EJ, Bennett DA, Dekoskv ST: Cholinergic plasticity in hippocampus of individuals with mild cognitive impairment: correlation with Alzheimer's neuropathology. J Alzheimers Dis 2003;5:39-48.